PCSRF is currently funding spinal injury research at the following universities
The cost of every spinal cord injury to the Australian society is significant. The estimated lifetime cost per incidence of quadriplegia is $9.5 million. The total annual cost of spinal cord injury in Australia is estimated to be $2 billion. Australia’s most promising hope of a cure right now is estimated to cost $30 million required to progress to the first human clinical trial.
The Perry Cross Spinal Research Foundation has one end goal - to find a cure for paralysis for all and improve the quality of life for those living with or affected by it. It has raised and injected over $12 million dollars into specific spinal injury cure projects within Australia and continues to work tirelessly to fundraise, lobby and facilitate relationships required to ensure an urgent cure is at the forefront of Australia’s medical agenda.
Axonal Regeneration
Mechanisms of Axonal Regeneration after central nervous system injury
Growth Factor Project
A new treatment for acute spinal cord injury – combination growth factor delivery to reduce paralysis after spinal cord injury
Olfactory Glia Project
Manipulating the selective activation of olfactory ensheathing cells for the repair of injured spinal cord.
Nerve Bridge Project
Funding to develop a new generation of nerve bridges to repair the injured spinal cord
World-leading Griffith University research into the development of a cell-based therapy for treating spinal cord injuries has received a $5.7 million boost from the Queensland Government.
Find out moreThe Perry Cross Spinal Research Foundation invites research funding proposals aimed at working towards a cure for spinal cord injuries.
Address
PO Box 8244 GCMC Qld 9726
Sub heading here
[FORM_HERE]A legacy gift to the Perry Cross Spinal Research Foundation will help us continue the journey to discover a cure for paralysis and its many complexities.
You can help people across the world to walk again. We can’t thank you enough for considering us.
Please contact us on
0457 277 579 for a confidential discussion.